Establishing Costs for Commercial Chimeric Antigen Receptor T-Cell (Tisagenlecleucel; Kymriah) in Children and Young Adult B-Cell Acute Lymphoblastic Leukemia: A Merged Analysis from the Pediatric Real-World CAR Consortium (PRWCC) and Pediatric Health Information System (PHIS)

Autor:	Satwani, Prakash, Chao, Karen, Lopez-Garcia, Maria, Hall, Matt, Jin, Zhezhen, Winestone, Lena E., Friedman, Danielle, Phelan, Rachel, Baggott, Christina, John, Samuel, Pacenta, Holly L, Laetsch, Theodore W, Phillips, Christine L, Verneris, Michael R., Fabrizio, Vanessa A., Keating, Amy K., Talano, Julie A, Moskop, Amy, Baumeister, Susanne H.C., Qayed, Muna, Myers, Doug, Hall, Erin M., Prabhu, Snehit, Nguyen, Khanh, Mackall, Crystal L., Lin, John Kent, Goldhaber-Fiebert, Jeremy, Schultz, Liora Michal
Zdroj:	In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S224-S225
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect